In a multicenter registry-based cohort reported in the USA, PLWH with CD4+ cell count less than 200 cells/μL was associated with increased risk of COVID-19 related mortality and hospitalization compared to those who have higher CD4+ cell count [50••]. This evidence concerns the gene CD4 and COVID-19.